Publication | Open Access

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

First-line TherapyOpen-label ExtensionsAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyPharmacotherapyAntiviral DrugHivWeek 192Medicine